French researchers reported on the use of synthetic CBD in a 15-year-old SCD patient suffering from chronic refractory pain in his spine, thorax, and knee. Prior to CBD treatment, the patient had required prolonged hospitalizations due to chronic pain. Following two weeks of CBD treatment, the patient experienced “a complete regression of pain.” During 10 months of treatment, the patient did not require any further hospitalizations.Authors concluded: “We report here for the first time a case of refractory chronic pain with dramatic improvement after CBD treatment in an adolescent with SCD. … As it seems to be a well-tolerated drug, CBD could represent a promising therapeutic perspective for patients with SCD suffering from chronic pain.” Survey data indicates that patients with SCD often consume cannabis for symptom management.
Source: Cannabis & Tech Today